Judge Won't Toss Birth Defect Claims In Zofran MDL
A Massachusetts federal judge on Friday nixed GlaxoSmithKline PLC's bid to dismiss all claims in multidistrict litigation alleging that the drug company's "off-label" promotion of its anti-nausea drug Zofran for morning...To view the full article, register now.
Already a subscriber? Click here to view full article